Please assess the completion status of the following clinical trial:

Trial Title: Robotic Seed Implantation for Prostate Cancer Brachytherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed, adenocarcinoma of the prostate, clinical stage T1c-T2b, NX, N0, M0.~* Zubrod status 0-1.~* Prostate tumor biopsy grading by Gleason score classification is mandatory prior to registration~* No prior pelvic radiation or chemotherapy for any reason; induction hormonal therapy beginning \< or = 6 months prior to registration is acceptable.~* Prostate volume \< or = 65 cc prior to registration, or planned use of LHRH agonist therapy for reduction of prostate volume. If LHRH agonist therapy is used to reduce prostate volume, then prostate volume must be \< or = 65 cc on the routine pre-implant volume study to be eligible for the study.~* Gleason score 6, or Gleason Score 7 if both , or = 33% of biopsy cores contain cancer and PSA level is \< or = 10 ng/mL.~* AUA voiding symptoms score \< or = 15.~* Prostate specific antigen (PSA) prior to study entry (and prior to any hormone treatment if given); must be \< or = 20 ng/ml.~* Patients must sign a study-specific consent form prior to registration (Standard of care: only the standard consent form must be signed).~* Patient must be \> or = 40 years old.~Exclusion Criteria:~* Stage T2c, T3 or T4 disease.~* Lymph node involvement (pathological N1)~* Evidence of distant metastases (M1)~* Gleason score 8-10.~* Prostate specific antigen (PSA) prior to study entry \> 20 ng/mL.~* AUA voiding symptoms score \> 15.~* Radical surgery for carcinoma of the prostate.~* Previous hormonal therapy beginning \> 6 months prior to registration~* Previous or concurrent cancers other than basal or squamous cell skin cancers unless disease- free for \> or = 5 years.~* Major medical or psychiatric illness which, in the investigator's opinion, would prevent completion of treatment and would interfere with follow-up and/or completion of HRQoL questionnaires (not a condition for ineligibility in Standard of care).~* Prior TURP~* Hip prosthesis

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Implant (Type: EXPERIMENTAL): Robotic implantation of brachytherapy seeds to treat prostate cancer

Based on this trial design, predict the completion outcome and termination type (if applicable).